ARTICLE | Company News
SQI Diagnostics deal
March 31, 2014 7:00 AM UTC
SQI expanded its deal to develop a custom multiplex test for a drug from an undisclosed pharma. Under the expansion, SQI will develop a 21-plex protein microarray for identifying immunogenic regions w...